Both in Pharmaceuticals
Regeneron Pharmaceuticals vs Roivant Sciences
Over the past year REGN returned +44.5% and ROIV returned +88.3%; their daily moves had a correlation of 0.18.
REGN +44.5% ROIV +88.3%Growth of $1, one year, split-adjusted
| Metric | REGN | ROIV |
|---|---|---|
| Price | $927.89 | $36.91 |
| Market cap | $95.99B | $26.66B |
| Today | +13.33% | −1.63% |
| 1 month | +26.3% | +4.0% |
| 6 months | +32.3% | +32.6% |
| Year to date | +20.2% | +70.1% |
| 1 year | +42.1% | +96.7% |
| Revenue growth (YoY) | +36.3% | −33.5% |
| Gross margin | 88.8% | 100.0% |
| Net margin | 38.1% | −13164.8% |
| P/E (TTM) | 19.9× | — |
| Price / sales | 5.7× | 3,539.7× |
| Net cash | $6.59B | $3.84B |
| Dividend yield | 0.41% | — |
| Volatility (60d) | 37.0% | 49.2% |
| Short % of float | 2.2% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).